Danaher (NYSE:DHR) Upgraded to Strong-Buy at StockNews.com

StockNews.com upgraded shares of Danaher (NYSE:DHRGet Rating) from a buy rating to a strong-buy rating in a report published on Tuesday morning.

DHR has been the subject of a number of other reports. JPMorgan Chase & Co. lowered their price target on Danaher from $350.00 to $315.00 and set an overweight rating for the company in a report on Friday, October 21st. Royal Bank of Canada dropped their price target on Danaher from $318.00 to $302.00 and set an outperform rating on the stock in a research report on Friday, October 21st. Deutsche Bank Aktiengesellschaft initiated coverage on Danaher in a research report on Tuesday, December 13th. They set a buy rating and a $310.00 price target on the stock. Credit Suisse Group lowered Danaher from an outperform rating to a neutral rating and dropped their price target for the company from $315.00 to $300.00 in a research report on Thursday, January 5th. Finally, Benchmark downgraded Danaher from a buy rating to a hold rating and set a $325.00 target price on the stock. in a research note on Monday, October 24th. Three analysts have rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of Moderate Buy and a consensus target price of $310.46.

Danaher Stock Down 2.0 %

Shares of NYSE:DHR opened at $271.58 on Tuesday. The stock’s 50-day moving average price is $266.13 and its two-hundred day moving average price is $268.98. The company has a current ratio of 1.78, a quick ratio of 1.38 and a debt-to-equity ratio of 0.41. Danaher has a 12-month low of $233.71 and a 12-month high of $303.82. The firm has a market cap of $197.70 billion, a price-to-earnings ratio of 30.01, a PEG ratio of 2.21 and a beta of 0.82.

Danaher (NYSE:DHRGet Rating) last issued its quarterly earnings results on Tuesday, January 24th. The conglomerate reported $2.87 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.45 by $0.42. Danaher had a return on equity of 18.33% and a net margin of 21.65%. The firm had revenue of $8.37 billion for the quarter, compared to analyst estimates of $7.90 billion. During the same period last year, the company earned $2.69 EPS. The firm’s quarterly revenue was up 2.7% on a year-over-year basis. On average, research analysts forecast that Danaher will post 10.55 EPS for the current year.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, January 27th. Shareholders of record on Friday, December 30th will be paid a $0.25 dividend. This represents a $1.00 annualized dividend and a dividend yield of 0.37%. The ex-dividend date of this dividend is Thursday, December 29th. Danaher’s dividend payout ratio is 11.05%.

Insider Activity at Danaher

In other Danaher news, EVP Joakim Weidemanis sold 9,508 shares of the business’s stock in a transaction that occurred on Monday, November 28th. The stock was sold at an average price of $266.60, for a total transaction of $2,534,832.80. Following the transaction, the executive vice president now owns 71,498 shares of the company’s stock, valued at $19,061,366.80. The sale was disclosed in a document filed with the SEC, which is available through this link. In related news, EVP Joakim Weidemanis sold 9,508 shares of the business’s stock in a transaction that occurred on Monday, November 28th. The stock was sold at an average price of $266.60, for a total value of $2,534,832.80. Following the completion of the sale, the executive vice president now directly owns 71,498 shares in the company, valued at $19,061,366.80. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CFO Matthew Mcgrew sold 18,935 shares of the business’s stock in a transaction that occurred on Friday, November 11th. The shares were sold at an average price of $274.72, for a total value of $5,201,823.20. Following the completion of the sale, the chief financial officer now owns 29,634 shares of the company’s stock, valued at $8,141,052.48. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 38,538 shares of company stock valued at $10,424,284. 11.20% of the stock is owned by insiders.

Institutional Investors Weigh In On Danaher

Several institutional investors have recently made changes to their positions in the stock. Steward Financial Group LLC raised its position in Danaher by 330.4% during the second quarter. Steward Financial Group LLC now owns 99 shares of the conglomerate’s stock valued at $25,000 after purchasing an additional 76 shares in the last quarter. Goodman Advisory Group LLC acquired a new position in Danaher during the second quarter valued at approximately $27,000. My Personal CFO LLC acquired a new position in Danaher during the fourth quarter valued at approximately $29,000. Moisand Fitzgerald Tamayo LLC raised its position in Danaher by 5,850.0% during the third quarter. Moisand Fitzgerald Tamayo LLC now owns 119 shares of the conglomerate’s stock valued at $31,000 after purchasing an additional 117 shares in the last quarter. Finally, Investors Asset Management of Georgia Inc. GA ADV acquired a new position in Danaher during the second quarter valued at approximately $32,000. 77.26% of the stock is currently owned by institutional investors.

About Danaher

(Get Rating)

Danaher Corp. operates as a medical company, which designs, manufactures, and markets professional, medical, industrial, and commercial products and services. It operates through the following segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, to understand the causes of disease, identify new therapies and test new drugs and vaccines.

See Also

Analyst Recommendations for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.